NCT03941184View on ClinicalTrials.gov

Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity

CompletedOBSERVATIONAL
Enrollment

114

Participants

Timeline

Start Date

January 1, 1995

Primary Completion Date

November 10, 2020

Study Completion Date

November 10, 2020

Conditions
SCADAddison DiseaseAnkylosing SpondylitisAntiphospholipid Antibody SyndromeCeliac DiseaseCrohn DiseaseDermatomyositisPolymyositisGuillain-Barre SyndromeHepatitis, AutoimmuneGraves DiseaseHashimoto ThyroiditisMultiple SclerosisMyasthenia GravisPernicious AnemiaPolymyalgia RheumaticaPrimary Biliary CirrhosisPsoriasisRheumatoid ArthritisSystemic SclerosisSjögren SyndromeSystemic Lupus ErythematosusTakayasu ArteritisType 1 Diabetes MellitusUlcerative ColitisUveitisVasculitisVitiligoRaynaud
Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER